Abstract
Background: Copeptin levels reflect vasopressin activity and help classify osmoregulatory disorders. There is limited pediatric experience using copeptin to diagnose and manage diabetes insipidus, syndrome of inappropriate antidiuretic hormone secretion (SIADH), and bi- or tri-phasic postsurgical osmoregulatory disorders. In this report, we describe serial copeptin levels in an infant who developed transient SIADH after neurosurgery. Case Description: A 4-month-old infant with no prior pituitary dysfunction underwent endoscopic fenestration of a large arachnoid cyst (3.5 × 4.7 × 3.8 cm). He developed SIADH on postoperative day 4 with seizures, hyponatremia (sodium 121 mmol/L), and concentrated urine (535 mOsm/kg). His initial copeptin level was inappropriately high in the context of his hyponatremia. Copeptin levels decreased as his SIADH resolved. Serial copeptin levels correlated to the infant’s increased ability to dilute urine. Conclusion: Copeptin levels in this infant are consistent with levels described in adults and older children. Obtaining copeptin levels may improve providers’ ability to quickly diagnose and manage SIADH amongst other heterogeneous causes of hyponatremia. Lastly, trending copeptin levels improved providers’ ability to monitor SIADH progression, and may allow preemptive fluid titration for children with bi- or tri-phasic shifts in osmoregulation after neurological procedures.
References
1.
Fenske
W
, Sandner
B
, Christ-Crain
M
. A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis
. Best Pract Res Clin Endocrinol Metab
. 2016
Mar
;30
(2
):219
–33
.
[PubMed]
1521-690X2.
Fenske
W
, Refardt
J
, Chifu
I
, Schnyder
I
, Winzeler
B
, Drummond
J
, et al. A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus
. N Engl J Med
. 2018
Aug
;379
(5
):428
–39
.
[PubMed]
0028-47933.
Tuli
G
, Tessaris
D
, Einaudi
S
, Matarazzo
P
, De Sanctis
L
. Copeptin role in polyuria-polydipsia syndrome differential diagnosis and reference range in paediatric age
. Clin Endocrinol (Oxf)
. 2018
Jun
;88
(6
):873
–9
.
[PubMed]
0300-06644.
Winzeler
B
, Cesana-Nigro
N
, Refardt
J
, Vogt
DR
, Imber
C
, Morin
B
, et al. Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study
. Lancet
. 2019
Aug
;394
(10198
):587
–95
.
[PubMed]
0140-67365.
Morgenthaler
NG
, Struck
J
, Alonso
C
, Bergmann
A
. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin
. Clin Chem
. 2006
Jan
;52
(1
):112
–9
.
[PubMed]
0009-91476.
Fenske
W
, Störk
S
, Blechschmidt
A
, Maier
SG
, Morgenthaler
NG
, Allolio
B
. Copeptin in the differential diagnosis of hyponatremia
. J Clin Endocrinol Metab
. 2009
Jan
;94
(1
):123
–9
.
[PubMed]
0021-972X7.
Vergier
J
, Fromonot
J
, Alvares De Azevedo Macedo
A
, Godefroy
A
, Marquant
E
, Guieu
R
, et al. Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: the copeptin approach
. Arch Pediatr
. 2018
Jan
;25
(1
):45
–7
.
[PubMed]
0929-693X8.
Burckhardt
MA
, Wellmann
M
, Fouzas
S
, Lapaire
O
, Burkhardt
T
, Benzing
J
, et al. Sexual disparity of copeptin in healthy newborn infants
. J Clin Endocrinol Metab
. 2014
Sep
;99
(9
):E1750
–3
.
[PubMed]
0021-972X9.
Wellmann
S
, Koslowski
A
, Spanaus
K
, Zimmermann
R
, Burkhardt
T
. Fetal Release of Copeptin in Response to Maternal Oxytocin Administration: A Randomized Controlled Trial
. Obstet Gynecol
. 2016
Oct
;128
(4
):699
–703
.
[PubMed]
0029-784410.
Summanen
M
, Seikku
L
, Rahkonen
P
, Stefanovic
V
, Teramo
K
, Andersson
S
, et al. Comparison of Umbilical Serum Copeptin Relative to Erythropoietin and S100B as Asphyxia Biomarkers at Birth
. Neonatology
. 2017
;112
(1
):60
–6
.
[PubMed]
1661-780011.
Rouatbi
H
, Zigabe
S
, Gkiougki
E
, Vranken
L
, Van Linthout
C
, Seghaye
MC
. Biomarkers of neonatal stress assessment: A prospective study
. Early Hum Dev
. 2019
Oct
;137
:104826
.
[PubMed]
0378-378212.
Williams
CN
, Riva-Cambrin
J
, Bratton
SL
. Etiology of postoperative hyponatremia following pediatric intracranial tumor surgery
. J Neurosurg Pediatr
. 2016
Mar
;17
(3
):303
–9
.
[PubMed]
1933-070713.
Lindsay
RS
, Seckl
JR
, Padfield
PL
. The triple-phase response—problems of water balance after pituitary surgery
. Postgrad Med J
. 1995
Jul
;71
(837
):439
–41
.
[PubMed]
0032-547314.
Christ-Crain
M
. Diabetes insipidus - new concepts for diagnosis
. Neuroendocrinology
. 2020
Jan
.
[PubMed]
0028-383515.
Fenske
W
, Quinkler
M
, Lorenz
D
, Zopf
K
, Haagen
U
, Papassotiriou
J
, et al. Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome—revisiting the direct and indirect water deprivation tests
. J Clin Endocrinol Metab
. 2011
May
;96
(5
):1506
–15
.
[PubMed]
0021-972X16.
Timper
K
, Fenske
W
, Kühn
F
, Frech
N
, Arici
B
, Rutishauser
J
, et al. Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study
. J Clin Endocrinol Metab
. 2015
Jun
;100
(6
):2268
–74
.
[PubMed]
0021-972X17.
Winzeler
B
, Zweifel
C
, Nigro
N
, Arici
B
, Bally
M
, Schuetz
P
, et al. Postoperative Copeptin Concentration Predicts Diabetes Insipidus After Pituitary Surgery
. J Clin Endocrinol Metab
. 2015
Jun
;100
(6
):2275
–82
.
[PubMed]
0021-972X18.
Refardt
J
, Winzeler
B
, Christ-Crain
M
. Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis
. Clin Endocrinol (Oxf)
. 2019
Jul
;91
(1
):22
–32
.
[PubMed]
0300-066419.
Nass
RD
, Sassen
R
, Elger
CE
, Surges
R
. The role of postictal laboratory blood analyses in the diagnosis and prognosis of seizures
. Seizure
. 2017
Apr
;47
:51
–65
.
[PubMed]
1059-1311© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
